Prof. Servaas A. Morré, PhD
Head of the Laboratory of Immunogenetics, Dept. of Microbiology and Infection Control, VU University Medical Centre, Amsterdam, The Netherlands
Director of the Institute for Public Health Genomics, Dept Genetics and Cell Biology, University Maastricht, Maastricht, The Netherlands
Coordinator of the Dutch Chlamydia trachomatis Reference Laboratory on
behalf of the Centre of Infectious Disease Control (CIb) at the National Institute of Public Health and the Environnment (RIVM), Bilthoven, The Netherlands
Education: He graduated at the VU University, The Netherlands, in Biochemistry and Molecular Biology in 1994. He did internships on plant genetics and processing of ribosomal RNAs. His PhD thesis (1999) was on the epidemiology, transmission, natural course, diagnostics and immunopathogenesis of human urogenital Chlamydia trachomatis infections. Finally, in 2009-2010 he got his Master in Biobusiness and Entrepreneurship.
Positions: He is currently working as Head of the Laboratory of Immunogenetics (since 2001), VU University medical center, Amsterdam and as Director of the Institute of Public Health Genomics (IPHG) (since 2011), University of Maastricht. From Feb 2012 he is Professor Host-pathogen Genomics in Public Health at IPHG. Since the 1st of Sept 2009 the coordinates the Dutch Chlamydia trachomatis Reference Laboratory for the RIVM. Finally, he is founder and director of several spin-off companies all located inside the VU University Medical Center.
Studies abroad: As an Erasmus Fellow he studied at the Universidade Do Porto, Laboratório de Genética Molecular, Portugal, on POLO: an essential kinase for mitosis in Drosophila melanogaster. As a postdoc, the Van Coeverden Adriani Foundation made it possible to extend his Chlamydial research at the Department of Infectious Diseases, The City of Hope Medical Center, California, USA, in collaboration with Dr. Joseph Lyons, specialists in murine modelling, he made in a period of 5 years yearly visits, the longest 4 months.
Research, grants and consortia: He is working on infectious diseases for more than 20 years and has over 180 publications (H-Index=36), from which most are on Chlamydia trachomatis. His research is for the major part focused on the immunogenetics of infectious diseases with special attention to Chlamydia trachomatis and Bacterial meningitis. He was Scientific Consortium Director, of the European Framework Programme 6 on functional genomics research entitled: “Contribution of molecular epidemiology and host-pathogen genomics to understand Chlamydia trachomatis disease with 20 European, African and US groups. This consortium is extended via new collaborative activities including a EuroTransBio grant (Start 2012) and a Eurostars grant (Start 2015) into a spin-in company (TubaScan Ltd). In addition, he is PI in 5 other (EU) grants. As a partner he is participating in several other European programmes and grants.
Organisation on scientific meetings: He organised since 2004 12 times the “Annual Amsterdam Chlamydia Meeting” (AACM), in 2016 the 12th AACM was organised. In July 2005 at the 16th Biennial meeting of the International Society for Sexually Transmitted Diseases Research he was a member of the Scientific Committee and organized amongst others the workshop “Immunogenetics of Chlamydia trachomatis Infections”. He was organizing Committee member of 6th Meeting of the European Society for Chlamydia Research, University of Aarhus, Aarhus, Denmark, July 1-4, 2008 and at this meeting also session organizer: “Immunogenetics of Chlamydia trachomatis infections”. He was the organizer of the 7th Meeting of the European Society for Chlamydia Research in 2012 (1-6 July) in Amsterdam, a meeting held only once every 4 years. Finally, in September 2016 his tender for organizing the 2018 International Chlamydia meeting was evaluated by the International Board during a side-visit and awarded and held 1-6 July 2018.